Pill controversy put to rest
11th March 2016
An Australian-led study has given the all-clear to oral contraceptives that contain drospirenone.
This follows concerns that the ingredient places women at increased risk of venous thromboembolism (VTE).
The study, which compared the drospirenone-containing contraceptives with levonorgestrel and other progestins failed to find a significant difference in VTE